MEDICINAL CANNABIS IN PARKINSON DISEASE: REAL-LIFE PATIENTS’ EXPERIENCE.
Balash Y., Bar-Lev Schleider L., Korczyn AD., Shabtai H., Knaani J., Rosenberg A., Baruch Y., Djaldetti R., Giladi N,. Gurevich T.
Clin Neuropharmacol. 2017 Nov/Dec;40(6):268-272. doi: 10.1097/WNF.0000000000000246.
The aim of this interview-based study was to assess the effects of medicinal cannabis on symptoms of Parkinson disease. The results of the retrospective survey, based on interviews with 47 patients show that medicinal cannabis can improve symptoms of Parkinson disease in the initial stages.
At ANTG, we are uniquely well-positioned to supply the domestic market and become the first medicinal cannabis company in Australia to export cannabis flower for commercial purposes to the EU. Interested in investing in medicinal cannabis? Read what sets ANTG apart.